axicabtagene ciloleucel
gilead,daiichi sankyo
['zuma-7', 'axi-cel', 'crispr']
#ash22 subsequent therapies after 2l axi-cel or soc in zuma-7 47% in axi-cel arm vs 71% in soc got 3l therapy findings may suggest that axi-cel in 2l had better outcomes than soc arm who got axi-cel in 3l 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??